There are different monitoring visits that a site needs to prepare for: site selection visits, site initiation visits, interim monitoring visits, close out visits, and pre-audit visits. In this video I explain how any clinical research sites can better prepare for these types of monitoring visits.
In this video, Chris Sauber and myself discuss how clinical researcher entrepreneurs can get better at sales, and how much money a startup clinical research site can realistically make. I hope you find some value in this 20 minute video.
In the clinical research industry, it is quite easy to get lost in the details of what we are actually doing. For new entrants into the field, I have already created a 2 hour crash course of what clinical research entails, however I realize many of you are still having a hard time understanding the bigger picture in this line of work. In this interview I conducted with a brand new student who has enrolled in my CRA Academy, I answer some of his questions and give him a general overview of the entire clinical research industry including many of the key moving parts. I hope this will be able to help many others out there!
Business development is essentially a fancy way of calling it when one business needs to convince another business to work with them. Clinical research is primarily a business to business endeavor on the backend (when sites or CRO's pitch Sponsors for the right to conduct a study), and a business to consumer endeavor on the front end (sites and CRO's recruiting study participants to enroll in the studies). In this video, my business partner and I discuss the various ways we have been successful in bringing new studies to our clinics and our clients. Would love to hear some of your strategies as well Guru Nation!
I was fortunate enough to have one of the industry's most innovative CEO's, Ibs Mahmood from Drug Dev come on the show and share his insights in regards to what is happening in the clinical research industry. We especially dive into issues such as clinical trial site payments, how risk based monitoring is affecting research clinics, and also how big data is allowing for transparent and clear site metrics to be tracked and shared by and amongst sponsors and CRO's.